Tandem Diabetes Care TNDM Enterprise value

Enterprise value at other companies

InsuletPODD

$10.99B-51.4%

MedtronicMDT

$131.22B-3.2%

Beta BionicsBBNX

$660.48M+1.1%

Embecta Corp.EMBC

$1.48B-21.5%

AdaptHealthAHCO

$3.57B+1.7%

MannkindMNKD

$1.27B+9.1%

FAQ

What is Tandem Diabetes Care's enterprise value?

Tandem Diabetes Care (TNDM) reported enterprise value of $1.71B in Q2 2026.

How has Tandem Diabetes Care's enterprise value changed year-over-year?

Tandem Diabetes Care's enterprise value decreased by 1.1% year-over-year, from $1.73B to $1.71B.

What is the long-term trend for Tandem Diabetes Care's enterprise value?

Over 5 years (2020 to 2025), Tandem Diabetes Care's enterprise value has grown at a -21.0% compound annual growth rate (CAGR), from $6.01B to $1.84B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.